Myricx Bio

📍 London, United Kingdom👥 15 employees💰 Last funded Jun 2024
Biotechnology Research🌐 myricxbio.com
Website LinkedIn
We are a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in Myricx Bio?
Myricx Bio has 2 investors on record on gritt.io.
When did Myricx Bio last raise funding?
The most recent investment in Myricx Bio recorded on gritt.io was in June 2024.
What industry is Myricx Bio in?
Myricx Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Myricx Bio based?
Myricx Bio is headquartered in London, United Kingdom.